Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. cardiosource. org), the American Heart Association …

Acute myocardial infarction has traditionally been divided into ST elevation or non-ST
elevation myocardial infarction; however, therapies are similar between the two, and the …

Background Timely revascularization with percutaneous coronary intervention (PCI) reduces
death following myocardial infarction. We evaluated if a sex gap in symptom‐to‐door (STD) …

Human ESC-derived mesenchymal stem cell (MSC)-conditioned medium (CM) was
previously shown to mediate cardioprotection during myocardial ischemia/reperfusion injury …

Background Recent reductions in average door-to-balloon (D2B) times have not been
associated with decreases in mortality at the population level. We investigated this …

The term acute coronary syndrome (ACS) refers to any group of clinical symptoms
compatible with acute myocardial ischemia and includes unstable angina (UA), non—ST …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through November 2010, as well as selected …

Context Timely reperfusion therapy is recommended for patients with ST-segment elevation
myocardial infarction (STEMI), and door-to-balloon delay has been proposed as a …

D. Medication Assessment............................................ 610 1. Beta Blockers....................................
................. 609 2. Nitroglycerin...................................................... 610 3. Inhibition of the Renin …

Background—Although the relationship between mortality and time delay to treatment has
been demonstrated in patients with acute ST-segment elevation myocardial infarction …